|
| Press Releases |
|
 |
|
| Friday, September 9, 2022 |
|
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Tuesday, July 19, 2022 |
|
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
| Thursday, February 17, 2022 |
|
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
| Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
| Wednesday, February 16, 2022 |
|
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
| Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Olympus Appoints New CEO
Apr 25, 2025 22:43 JST
|
|
|
Graphene Manufacturing Group Provides Quarterly ATM Sales Update
Apr 25, 2025 20:29 HKT/SGT
|
|
|
Edvantage Group Announces FY2025 Interim Results
Apr 25, 2025 20:05 HKT/SGT
|
|
|
TIME Interconnect Technology Limited Announces Final Results For The Year Ended 31 December 2024
Apr 25, 2025 20:03 HKT/SGT
|
|
|
汇聚科技有限公司公布截至二零二四年十二月三十一日止末期业绩
Apr 25, 2025 17:41 HKT/SGT
|
|
|
NEC achieves Japan's longest terrestrial wireless optical communication over 10 km
Apr 25, 2025 17:50 JST
|
|
|
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT/SGT
|
|
|
Olympus Appoints New CEO
Apr 25, 2025 15:30: JST
|
|
|
極海傳媒助力紐曼出海：從中國智造到東南亞C位
Apr 25, 2025 15:27 HKT/SGT
|
|
|
米国株式アクティブ残高9年連続世界No.1ティー・ロウ・プライス[1] Ｒ＆Ｉファンド大賞2025最優秀ファンド賞を受賞
Apr 25, 2025 15:15: JST
|
|
|
极海传媒助力纽曼出海：从中国智造到东南亚C位
Apr 25, 2025 15:03 HKT/SGT
|
|
|
中滙集團公佈2025財年中期業績
Apr 25, 2025 14:14 HKT/SGT
|
|
|
Tsuburaya Productions Memperkenalkan Era Baru Penjahat Dengan “Shadow of Undying Vengeance” – Booster Pek Bertemakan Kaiju Pertama Dalam Permainan Kad Ultraman
Apr 25, 2025 13:00 HKT/SGT
|
|
|
Tsuburaya Productions Giới Thiệu Kỷ Nguyên Phản Diện Mới với Bộ Bài " Shadow of Undying Vengeance " – Bộ Mở Rộng Ultraman Card Game Đầu Tiên Tập Trung Vào Kaiju
Apr 25, 2025 13:00 HKT/SGT
|
|
|
Tsuburaya Productions Menghadirkan Era Baru Para Penjahat dengan “Shadow of Undying Vengeance” – Booster Pack Bertema Kaiju Pertama dari Ultraman Card Game
Apr 25, 2025 13:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
